"Designing Growth Strategies is in our DNA"
The global transrectal ultrasound market size was valued at USD 204.8 Million in 2017 and projected to reach USD 291.2 Million by the end of 2025, exhibiting a CAGR of 4.5%.
Increasing R&D focus of market players operating in the ultrasound segment, is leading to introduction of new and innovative systems in the market. Increasing prevalence of prostate cancer and benign prostatic hyperplasia, along with increasing government initiatives promoting early diagnosis of prostate cancer, and technology advances in TRUS devices are propelling the growth of the global market. The transrectal ultrasound market is projected to reach US$ 291.2 Mn by 2025.
Introduction of systems with improved and efficient imaging capabilities, incorporated with techniques facilitating MRI-US fusion biopsies, high-resolution ultrasound scanning, and real-time elastography for diagnosis of prostate cancer, are driving the shift of diagnostic approaches of prostate cancer from conventional to advanced techniques. The large and aging installed base in emerging countries such as China, and India, along with developing healthcare infrastructure in these countries, is propelling the increasing adoption of transrectal ultrasound systems.
Request a Free sample to learn more about this report.
"Launch of Innovative and Advanced Systems Steers Lucrative Growth Opportunities in Systems Segment"
Based on the product, the global TRUS market segments include systems and transducers. Systems dominated the global market in 2017, owing to higher demand coupled with comparatively higher cost of acquisition. Based on type, the transrectal ultrasound market segments include cart/ trolley-based, and portable. Based on application, the global market segments include diagnostic (prostate cancer, benign prostatic hyperplasia, and others), and image-guided treatment. Based on end user, the transrectal ultrasound market segments include hospitals & ASC’s, diagnostic laboratories, and others. Based on region, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
To know how our report can help streamline your business, Speak to Analyst
"Developing Hospital Infrastructure Fuels Demand for New Unit Shipments of Transrectal Ultrasound Systems in the Asia Pacific"
The Asia Pacific has a large and aging installed base of ultrasound systems, which is one primary factor fueling the demand for replacement unit shipments to drive the growth of the market in the region in 2017. This growth is further augmented by a rapidly developing hospital infrastructure and increasing per capita healthcare spending in countries such as China, India, and other southeast Asian countries, which is leading to rising demand for new unit shipments of transrectal ultrasound systems. In 2017, Asia Pacific accounted for around 26% of the transrectal ultrasound market share.
Asia Pacific Transrectal Ultrasound (TRUS) Market, 2017
To get more information on the regional analysis of this market, Request a Free sample
"Presence of a Diversified And Well-Established Portfolio for Urology Catapults BK Medical Holding Company, Inc."
The transrectal ultrasound market is characterized by a semi-consolidated environment, where the top 2-3 players dominated the global market in 2017, while other players also accounted for a significant share of the market. A well-established brand presence, diversified portfolio of ultrasound systems for urology, and widespread geographic presence have been factors responsible for the strong position of BK Medical Holding Company, Inc., in 2017. Other key players include GE Healthcare, Esaote SpA, Exact Imaging, The Prometheus Group, TELEMED, among others.
An Infographic Representation of Transrectal Ultrasound (TRUS) Market
To get information on various segments, share your queries with us
Introduction of systems focusing on specialty procedures including urology is transforming the landscape of the ultrasound market for diagnosis of prostate cancer and other urology diseases. The report on the market focuses on market size in terms of revenues (US$ Mn), of ultrasound systems and transducers, for the period 2014-2025.
The transrectal ultrasound market analysis offers information pertaining to various dynamics of the market including drivers, restraints, opportunities for market players in the market trends. The report analyzes and evaluates current market size, growth rates, and forecast of the global market, in regard to product (ultrasound systems, and transducers), type (cart/ trolley-based systems, portable systems), application (diagnostic applications: diagnosis of prostate cancer, benign prostatic hyperplasia, and other urological conditions; and image-guided treatment applications), and end-users (hospitals, diagnostic laboratories, and others).
The report also offers key insights related to different parameters including the prevalence of prostate cancer, and benign prostatic hyperplasia, key mergers and acquisitions in the market, technological advances in the TRUS market, and distribution analysis of major market players.
ATTRIBUTE | DETAILS |
By Product |
|
By Type |
|
By Application |
|
By End User |
|
By Geography |
|
Fortune Business Insights says that the Transrectal Ultrasound market was valued at USD 204.8 Million in 2017 and is projected to reach USD 291.2 Million by 2025.
In 2017, the Asia Pacific Transrectal Ultrasound (TRUS) market was valued at USD 53.9 Million.
Growing at a CAGR of 4.5%, the market will exhibit significant growth in the forecast period (2018-2025)
The systems segment in product type is expected to be the leading segment in this market during the forecast period.
Rising prevalence of prostate cancer and active government initiatives for early diagnosis are the major factors driving the market.
BK Medical Holding Company, Inc. and GE Healthcare are the top players in the market.
North America is expected to witness highest growth in the market during the forecast period.
The gradual shift towards advanced diagnostic tools for prostate cancer and favorable health reimbursement are the factors that are expected to drive the adoption of Transrectal Ultrasound (TRUS).
Active prostate cancer awareness programs and significant rise in number of well-equipped diagnostic centers are the major trends in the market